Close Menu

Becton Dickinson

The test detects chlamydia, gonorrhea, and trichomonas from a single patient sample.

The pre-market approval application is based on data collected during a two-year prospective study of more than 33,000 women.

Diagnostic systems strength was driven by strong growth in molecular and installations in Western Europe .

Nearly 8,000 patients participated in a screening study that used a PCR-based detection assay from Becton Dickinson, uncovering a 5 percent carrier rate.

The group hopes its proposed regulatory framework might strike a compromise between different industry stakeholders.

NEW YORK (GenomeWeb) — Researchers at Johns Hopkins University have performed the first validation of the Cepheid Xpert Flu assay in a population of emergency room patients with acute undifferentiated respiratory illness.

Roche's test becomes the second PCR-based MRSA test approved for clinical use in the US, joining Cepheid's Xpert MRSA/SA nasal assay for the GeneXpert PCR platform.

Pages